ArticleBMC psychiatry2026
Association of anhedonia with brain-derived neurotrophic factor and oxidative stress in bipolar disorder.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundIndividuals with bipolar disorder (BD) undergo depressed episodes, frequently characterized by anhedonia. Neurotrophic factors and oxidative stress are linked to anhedonia. The precise association between these biomarkers and anhedonia in individuals with BD remains unclear. This study primarily examined the potential relationships among brain-derived neurotrophic factor (BDNF), superoxide dismutase (SOD), catalase (CAT), and anhedonia in individuals with BD.
methodsThis study had 85 people diagnosed with bipolar disorder, of whom 61 exhibited depression symptoms. Additionally, there were 88 healthy control volunteers. The study thoroughly evaluated anticipatory and consummatory pleasure, childhood adversity, oxidative stress indicators, and BDNF levels in depressed BD patients and healthy controls. Partial correlation analysis and stepwise multiple linear regression analysis were employed to explore the relationships among oxidative stress indicators, BDNF and anhedonia.
resultsIn comparison to the healthy control group, the depressed BD group demonstrated markedly diminished anticipatory and consummatory pleasure, elevated anxiety and depression ratings, and increased childhood adversity. There was a significant difference in CAT levels between the two groups. In depressed BD patients, BDNF and CAT were moderately and negatively correlated with consummatory pleasure. The regression analysis indicated BDNF as a significant predictor of consummatory pleasure.
conclusionThese data suggested that the anhedonia is affected by BDNF and oxidative stresses, so offering a critical insight for addressing anhedonia in BD. CLINICAL TRIAL REGISTRATION NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.